Bayer grabs $14.2B loan for Merck consumer buy; AZ research exec sells $1M in stock; Forest wins pediatric extension for Namenda;

@FiercePharma: Top-read special report Monday: The top 10 best-selling diabetes drugs of 2013. Report | Follow @FiercePharma

@TracyStaton: Trending now @FiercePharma: Novo Nordisk lays out plans to recruit 6,000 workers in R&D, production. Story | Follow @TracyStaton

@EricPFierce: #OSHA seeks $500,000 in penalties against #API maker that no longer exists but it was bad player when it did. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Pfizer puts the heat on Novartis with FDA MenB filing. Story from FierceVaccines | Follow @CarlyHFierce

@JustinHFierce: China-manufactured weight loss drug Sport Burner has Prozac in it, icymi, says @FDArecalls. Notification | Follow @JustinHFierce

> Bayer inked a $14.2 billion acquisition loan to back its buyout of Merck's ($MRK) consumer health business, with underwriting from bank of America Merrill Lynch, BNP Paribas and Mizuho Bank. Report

> AstraZeneca's ($AZN) CMO Briggs Morrison cashed in about $1 million worth of his shares in the company at a sale price of $73.79 each, lower than the price Pfizer ($PFE) had proposed to pay for the company. Report

> Forest Laboratories ($FRX) nabbed an additional 6 months of market control for its Alzheimer's medications Namenda and Namenda XR under the FDA's pediatric exclusivity program. Release

> Sanofi Pasteur's Gardasil vaccine against the human papillomavirus was approved in Europe as a preventive against anal cancer. Report

> Roche's ($RHHBY) blood cancer drug Gazyvaro won approval for use in previously untreated chronic lymphocytic leukemia patients in Switzerland. Release

> Sucampo Pharmaceuticals won backing from the U.K.'s cost-effectiveness watchdogs for its drug Amitiza as a treatment for chronic constipation. Report

Medical Device News

@FierceMedDev: Obesity device before FDA panel despite not meeting primary endpoints - FierceMedicalDevices. Story | Follow @FierceMedDev

@StacyALawrence: 3-D printer Materialise slated to price $104M IPO - FierceMedicalDevices. More | Follow @StacyALawrence

@MichaelGFierce: UPenn team combats #Parkinsons with immunotherapy that targets neuron killers. Story from FierceBiotechResearch | Follow @MichaelGFierce

@EmilyWFierce: Chrono Therapeutics tackles smoking cessation with programmable monitoring system. Article from FierceDrugDelivery | Follow @EmilyWFierce

> Medtronic merger could give Covidien execs an $80M payout. More

> Another FDA setback for Boston Scientific's Watchman stroke-fighting device. Story

> Lawmakers question FDA oversight of mobile medical apps as market booms. Article

Biotech News

@FierceBiotech: Meet the new Novartis: Slimmer structure, same R&D commitment. More | Follow @FierceBiotech

@JohnCFierce: For everyone in San Diego or coming next week: Killer weather, the kind that makes you want to move here. | Follow @JohnCFierce

@DamianFierce: Rebuffed in its attempt on AstraZeneca's cancer pipeline, Pfizer teams with Cellectis for immunotherapies of its own. Story | Follow @DamianFierce

> Cash-flush Sage swings for a $69M IPO to fund its CNS program. Article

> Big biotech booms while pharma payrolls wither. Report

> Insmed snags a surprise 'breakthrough' tag for its up-and-down antibiotic. News

Drug Delivery News

> Protein from a fatal fungus may offer up meningitis treatment. Story

> Chrono Therapeutics tackles smoking cessation with programmable monitoring system. More

> Proteasome inhibitor delivered with cancer-killing viruses enhances effect. Item

> 'Onion' drug delivery vehicle has concentric layers for consistent dosing. Article

Diagnostics News

> Sequenom enlists Quest to help market its prenatal test. More

> Alere gets FDA clearance for rapid influenza test. Story

> Natera puts its prenatal know-how toward cancer diagnostics. Article

> Enterome teams up with Mayo for gut diagnostics. Report

> Navidea bags expanded FDA nod for Lymphoseek. News

> Israeli bladder cancer Dx outfit raises $5M in financing. Item

Pharma Marketing News

> Fake patient story wins a real-life marketing award? Discuss. Story

> How to speak on social media? Finally, the FDA offers more specific clues. More

> Today's pharma reps need the skills of doctors, lawyers, beggars--but not thieves. Article

> Pfizer, Novartis square off for tussle in meningitis vaccine market. Story

> J&J recruits a Hispanic family to be its reps in the Hispanic market. News

And Finally... HIV pill for prevention? A debate. Report

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.